By QPX9003, a novel antibiotic developed by Monash University researchers targeting antibiotic-resistant “superbugs” has achieved an important milestone in its clinical development, with the initial Phase 1 studies of the drug delivering very promising safety and tolerability results.
New antibiotic shows promising results in clinical trials
A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration
Comments